Satyavathi Bio-Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 37.00 Cr
- Paid Up Capital ₹ 36.50 Cr
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 5.00 Cr
- Revenue Growth -79.62%
- Profit Growth -152.71%
- Ebitda 76.08%
- Net Worth -72.88%
- Total Assets -80.90%
About Satyavathi Bio-Life Sciences
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230TG2005PLC092218
-
Company No.
092218
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
23 Nov 2005
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Satyavathi Bio-Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yalamanchili Naveen
|
Managing Director | 10-Oct-2011 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Janaki Yalamanchili
|
Director | 20-Jun-2019 | Current |
|
Dileep Pendurty
|
Whole-Time Director | 26-Mar-2018 | Current |
Financial Performance of Satyavathi Bio-Life Sciences.
Satyavathi Bio-Life Sciences Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 79.62% decrease. The company also saw a substantial fall in profitability, with a 152.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 72.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satyavathi Bio-Life Sciences?
In 2022, Satyavathi Bio-Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cyber Park Development & Construction Private LimitedDileep Pendurty is a mutual person
-
Sjk Infracon Private LimitedDileep Pendurty is a mutual person
-
Yjkr Powergen Private Limited
Dileep Pendurty is a mutual person
-
Optrex Finexim Pvt Ltd
Dileep Pendurty is a mutual person
-
Njsss Hisoft Private Limited
Dileep Pendurty is a mutual person
-
Ambhojini Agro Tech Llp
Yalamanchili Naveen is a mutual person
Charges (Loans)
₹0
₹5.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2013 | State Bank Of India | ₹5.00 Cr | Satisfied |
How Many Employees Work at Satyavathi Bio-Life Sciences?
Unlock and access historical data on people associated with Satyavathi Bio-Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satyavathi Bio-Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyavathi Bio-Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
